sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
aguggacagcagcuccuccacca | 1811 | WO2022231999A1 | Transmembrane protease, serine 6 (tmprss6) irna compositions and methods of use thereof | 20,221,103 | 224 | [
"MX",
"MY",
"CO",
"ZA",
"JP",
"CN",
"BR",
"CL",
"EP",
"EA",
"IL",
"US",
"CA",
"HK",
"NZ",
"SG",
"IN",
"AU",
"WO",
"KR",
"TW"
] | null |
aguggacagcagcuccuccacca | 1811 | WO2022231999A1 | COMPOSITIONS D'ARNI DE PROTÉASE TRANSMEMBRANAIRE, DE SÉRINE 6 (TMPRSS6) ET LEURS PROCÉDÉS D'UTILISATION | 20,221,103 | 224 | [
"MX",
"MY",
"CO",
"ZA",
"JP",
"CN",
"BR",
"CL",
"EP",
"EA",
"IL",
"US",
"CA",
"HK",
"NZ",
"SG",
"IN",
"AU",
"WO",
"KR",
"TW"
] | null |
aguggacagcagcuccuccacca | 2232 | WO2022231999A1 | Transmembrane protease, serine 6 (tmprss6) irna compositions and methods of use thereof | 20,221,103 | 224 | [
"MX",
"MY",
"CO",
"ZA",
"JP",
"CN",
"BR",
"CL",
"EP",
"EA",
"IL",
"US",
"CA",
"HK",
"NZ",
"SG",
"IN",
"AU",
"WO",
"KR",
"TW"
] | null |
aguggacagcagcuccuccacca | 2232 | WO2022231999A1 | COMPOSITIONS D'ARNI DE PROTÉASE TRANSMEMBRANAIRE, DE SÉRINE 6 (TMPRSS6) ET LEURS PROCÉDÉS D'UTILISATION | 20,221,103 | 224 | [
"MX",
"MY",
"CO",
"ZA",
"JP",
"CN",
"BR",
"CL",
"EP",
"EA",
"IL",
"US",
"CA",
"HK",
"NZ",
"SG",
"IN",
"AU",
"WO",
"KR",
"TW"
] | null |
ucgugagacuucuguguugca | 481 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucgugagacuucuguguugca | 481 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucgugagacuucuguguugca | 274 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucgugagacuucuguguugca | 274 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 593 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 593 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 719 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 719 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 231 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 231 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 711 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
uuguccagcuuuauugggaggcc | 711 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 46 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 46 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 356 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 356 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 47 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 47 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 357 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggagcaccguuaaggacaagu | 357 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 343 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 343 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 342 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 342 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 33 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 33 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 32 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
caagaccgccaaggaugcacu | 32 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggguauugaggucucaggcagcc | 161 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggguauugaggucucaggcagcc | 161 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggguauugaggucucaggcagcc | 523 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ggguauugaggucucaggcagcc | 523 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
aagacaugagaacauacuuuccc | 646 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
aagacaugagaacauacuuuccc | 646 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
aagacaugagaacauacuuuccc | 336 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
aagacaugagaacauacuuuccc | 336 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 346 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 346 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 37 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 37 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 36 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 36 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 347 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cgauggcuucaguucccugaa | 347 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucuuauccagcuuuauuagggac | 319 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucuuauccagcuuuauuagggac | 319 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucuuauccagcuuuauuagggac | 629 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ucuuauccagcuuuauuagggac | 629 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cauagcagcuucuuguccagcuu | 597 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cauagcagcuucuuguccagcuu | 597 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cauagcagcuucuuguccagcuu | 235 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cauagcagcuucuuguccagcuu | 235 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cuuauccagcuuuauuagggaca | 627 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cuuauccagcuuuauuagggaca | 627 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cuuauccagcuuuauuagggaca | 317 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
cuuauccagcuuuauuagggaca | 317 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
gagaauacugucccuuuuaagca | 227 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
gagaauacugucccuuuuaagca | 227 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
gagaauacugucccuuuuaagca | 589 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
gagaauacugucccuuuuaagca | 589 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 750 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 750 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 667 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 667 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 753 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 753 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 684 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 684 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 752 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 752 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 701 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 701 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 751 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 751 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 705 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 705 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 19 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 19 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 755 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 755 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 749 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 749 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 730 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 730 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 662 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 662 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 748 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 748 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 754 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 754 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 747 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 747 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 733 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 733 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 21 | JP2024147603A | アポリポタンパク質C3(APOC3)iRNA組成物およびその使用方法 | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
ugaauacugucccuuuuaagcaa | 21 | JP2024147603A | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 20,241,016 | 3 | [
"JP",
"US",
"AU",
"HK",
"CN",
"EP",
"CA",
"WO"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.